Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL513789 | 0.83 | ALDH1A1 (0.31) | ALDH1A1MAPTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16862449 | 0.80 | ALDH1A1 (0.38) | ALDH1A1MAPTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL514316 | 0.78 | ALDH1A1 (0.34) | ALDH1A1MAPTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1964874 | 0.77 | ALDH1A1 (0.34) | ALDH1A1SLC6A2SLC6A4SLC6A3KDM4E | |
| SCHEMBL16862460 | 0.77 | ALDH1A1 (0.38) | ALDH1A1MAPTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1967251 | 0.77 | ALDH1A1 (0.38) | ALDH1A1MAPTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL514096 | 0.76 | CMA1 (0.37) | ALDH1A1SLC6A2SLC6A4SLC6A3KDM4E | |
| SCHEMBL1967282 | 0.76 | KMT2A (0.39) | ALDH1A1KDM4E | |
| SCHEMBL16862452 | 0.75 | KDM4E (0.34) | ALDH1A1MAPTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL514567 | 0.74 | ALDH1A1 (0.33) | ALDH1A1MAPTSLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2420493-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | Nissan Chemical Industries, Ltd. (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | CBR3, CBR1, HDHD5 | ALDH1A1 1574/4885MAPT 4824/4885HPGD 3162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.